The original plan discussed with Shen Siyuan was to use the Jinggang University Medical College's project title to secure start-up capital from Jin Pharmaceutical Group. This would also facilitate hiring faculty and students from the Jinggang University Medical College and personnel from relevant hospital departments to participate in the research project.
Now that the first-phase paper was complete and the second-phase paper on the core mechanism of negative immune regulation was published, Wu Ting no longer needed to operate under the banner of the Jinggang University Medical College.
Once Wu Ting completed his thesis defense using the results and papers from the first and second phases, he could leverage their influence to enter business negotiations with Jin Pharmaceutical Group.
With their investment, he could legitimately return to City First Hospital and establish a laboratory for hepatitis B-related primary liver cancer that was entirely his own!
